Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group

被引：19
|
作者：
Guirado, M. [1 ]
Sanchez-Hernandez, A. [2 ]
Pijuan, L. [3 ]
Teixido, C. [4 ]
Gomez-Caamano, A. [5 ]
Cilleruelo-Ramos, A. [6 ]
机构：
[1] Hosp Gen Univ Elche, Dept Med Oncol, Elche 03203, Spain
[2] Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana 12002, Spain
[3] Bellvitge Univ Hosp, Dept Pathol, Lhospitalet De Llobregat 08907, Spain
[4] Hosp Clin Barcelona, Dept Pathol, Thorac Oncol Unit, IDIBAPS, C Villarroel 170, Barcelona 08036, Spain
[5] Univ Santiago de Compostela, Dept Radiat Oncol, Hosp Clin, Santiago De Compostela 15706, Spain
[6] Hosp Clin Univ Valladolid, Dept Thorac Surg, Valladolid 47005, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2022年 / 24卷 / 03期
关键词：
Lung neoplasms (MeSH); Quality indicators (MeSH); Quality of health care (MeSH); Multidisciplinary team; Tumor board; TEAM MEETINGS; CARE; ONCOLOGY; MANAGEMENT; IMPACT;
D O I：
10.1007/s12094-021-02712-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Multidisciplinary care is needed to decide the best therapeutic approach and to provide optimal care to patients with lung cancer (LC). Multidisciplinary teams (MDTs) are optimal strategies for the management of patients with LC and have been associated with better outcomes, such as an increase in quality of life and survival. The Spanish Lung Cancer Group has promoted this review about the current situation of the existing national LC-MDTs, which also offers a set of excellence requirements and quality indicators to achieve the best care in any patient with LC. Time and sufficient resources; leadership; administrative and institutional support; and recording of activity are key factors for the success of LC-MDTs. A set of excellence requirements in terms of staff, resources and organization of the LC-MDT have been proposed. At last, a list of quality indicators has been agreed to achieve and measure the performance of current LC-MDTs.
引用
收藏
页码：446 / 459
页数：14
相关论文
共 50 条
  • [1] Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group
    M. Guirado
    A. Sanchez-Hernandez
    L. Pijuan
    C. Teixido
    A. Gómez-Caamaño
    Á. Cilleruelo-Ramos
    Clinical and Translational Oncology, 2022, 24 : 446 - 459
  • [2] Measuring lung cancer quality indicators at the multidisciplinary team level
    Vinod, Shalini K.
    Sayaloune, Phan
    Berthelsen, Angela
    Bray, Victoria
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 158 - 158
  • [3] Development of a Virtual Multidisciplinary Lung Cancer Tumor Board in a Community Setting
    Stevenson, Marvaretta M.
    Irwin, Tonia
    Lowry, Terry
    Ahmed, Maleka Z.
    Walden, Thomas L.
    Watson, Melanie
    Sutton, Linda
    JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (03) : E77 - E80
  • [4] Development of a virtual multidisciplinary lung cancer tumor board in a community setting
    Stevenson, Marvaretta Miesha
    Irwin, Tonia
    Lowry, Terry
    Ahmed, Maleka Zafreen
    Walden, Thomas L.
    Sutton, Linda
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [5] Concordance Between Artificial Intelligence and Multidisciplinary Tumor Board for Lung Cancer
    Kim, M.
    Park, H.
    Kho, B.
    Park, C.
    Oh, I.
    Kim, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Outcomes of Patients with Metastatic Lung Cancer Presented in a Multidisciplinary Molecular Tumor Board
    Chu, L.
    Kelly, K.
    Gandara, D.
    Lara, P.
    Borowsky, A.
    Meyers, F.
    Mcpherson, J.
    Erlich, R.
    Almog, N.
    Schrock, A.
    Ali, S.
    Ross, J.
    Miller, V.
    Heilmann, A.
    Riess, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S986 - S986
  • [7] The Role of the Nuclear Medicine Specialist in the Multidisciplinary Tumor Board for Lung Cancer Treatment
    Tabain, A.
    Rogan, S. A.
    Puljic, I.
    Radic, J.
    Vucetic, B.
    Dzombeta, T. Regovic
    Palcic, M. Gomercic
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S506 - S507
  • [8] Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board
    Kim, Min-Seok
    Park, Ha-Young
    Kho, Bo-Gun
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Young-Chul
    Kim, Seok
    Yun, Ju-Sik
    Song, Sang-Yun
    Na, Kook-Joo
    Jeong, Jae-Uk
    Yoon, Mee Sun
    Ahn, Sung-Ja
    Yoo, Su Woong
    Kang, Sae-Ryung
    Kwon, Seong Young
    Bom, Hee-Seung
    Jang, Woo-Youl
    Kim, In-Young
    Lee, Jong-Eun
    Jeong, Won-Gi
    Kim, Yun-Hyeon
    Lee, Taebum
    Choi, Yoo-Duk
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 507 - 514
  • [9] Patterns of Multidisciplinary Tumor Board Utilization in the Management of Non-Small Cell Lung Cancer
    Rayburn, J. R.
    Wilshire, C. L.
    Gilbert, C. R.
    Louie, B. E.
    Aye, R. W.
    Farivar, A. S.
    Vallieres, E.
    Gorden, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Quality indicators in lung cancer: a review and analysis
    Chiew, Kim-Lin
    Sundaresan, Puma
    Jalaludin, Bin
    Chong, Shanley
    Vinod, Shalini K.
    BMJ OPEN QUALITY, 2021, 10 (03)
12345